Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.
Comparative Efficacy of Acupuncture Combined With Chinese Herbal Cream and Acupuncture Combined With Calcipotriol for Plaque Psoriasis.
Sponsor study identifier
interventional
28
1 country
1
Study Start
February 9, 2026
Actual (reported)Primary Completion
February 8, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
February 8, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Clinical trial which compares 2 treatment methods (1) Acupunture with a Chinese Herbal Cream and (2) Acupuncture with the standard treatment "calcipotriol" for patients with plaque psoriasis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 8, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 8, 2026
Actual (reported)February 9, 2026
Actual (reported)February 13, 2026
Actual (reported)February 8, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
February 8, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Psoriasis Area and Severity Index, PASI score
8 weeks
Dermatology Life Quality Index (DLQI)
8 weeks
Participant will receive 1 Acupuncture session per week for 8 weeks. And also receive Calcipotriol cream.
Participant will receive 1 Acupuncture session per week for 8 weeks. And also receive Chinese Herbal cream.
Bai-Hui (GV20), Fei-Shu (BL13), Ge-Shu (BL-17), Qu-Chi (LI11), Zu-San-Li (ST36), He-Gu (LI4), Tai-Chong (LR3), San-Yin-Jiao (SP6), Wei-Zhong (BL40)
Mae Fah Luang University
Muang, Chiangrai, 57100, Thailand
First Submitted
February 8, 2026
First Posted
February 13, 2026
Study Start
February 9, 2026
Actual (reported)Primary Completion
February 8, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Main API : Sophora flavescens Ait. (Ku-Shen), Cnidium monnieri (L.) Cuss. (She-Chuang-Zi), Prunus mume (Sieb.) Sieb.et Zucc. (Wu-Mei), Dictamnus dasycarpus Turcz. (Bai-Xian-Pi), Rheum palmatum L. (Da-Huang)
Contact the study team to confirm eligibility.
Study Completion
February 8, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
February 13, 2026
Record last verified: 2026-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: